AlphaTON Capital Corp (ATON) NPV

Sell:$0.35Buy:$0.36Price increased$0.01 (4.23%)

Prices delayed by at least 15 minutes
Sell:$0.35
Buy:$0.36
Change:Price increased$0.01 (4.23%)
Prices delayed by at least 15 minutes
Sell:$0.35
Buy:$0.36
Change:Price increased$0.01 (4.23%)
Prices delayed by at least 15 minutes

Company Information

About this company

AlphaTON Capital Corp., formerly Portage Biotech Inc., is a specialized digital asset treasury company. The Company is focused on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The Company implements a treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, the Company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. It is also advancing therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients. The Company engages in the drug development process and provides strategic counsel to guide development of immunotherapy assets and asset combinations.

Key people

Fiorenzo Villani
Executive Chairman of the Board, Chief Investment Officer
Brittany Kaiser
Chief Executive Officer, Director
Andrea Park
Chief Financial Officer
Robert Kramer
Chief Scientific Officer
Justin Fairchild
Vice President - Development
Brian Wiley
Chief Business Officer
F. Daniel Siciliano
Independent Director
Michael Terpin
Independent Director
Click to see more

Key facts

  • Shares in issue
    23.43m
  • EPIC
    ATON
  • ISIN
    VGG7185A1369
  • Location
    Virgin Islands (British)
  • Sector
    Financial
  • Industry
    Investment Services
  • Market cap
    $8.04m
  • Employees
    3
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.